MIRA INFORM REPORT

 

 

Report Date :

01.04.2008

 

 

IDENTIFICATION DETAILS

 

Name :

MERIDIAN MEDICARE LIMITED

 

 

Registered Office :

Village Shamti, Solan, 173212, Himachal Pradesh.

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

10.06.1997

 

 

Com. Reg. No.:

020064

 

 

CIN No.:

[Company Identification No.]

U24231HP1997PLC020064

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PTLM11669A

 

 

Legal Form :

Closely held Public Limited Liability Company

 

 

Line of Business :

Manufacturing and Marketing of Medicines.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 63120

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed Company having Satisfactory track. Trade relations are fair. Business is active. Payments are reported as usually correct and as per Commitments.

 

The Company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office / Factory :

Village Shamti, Solan, 173212, Himachal Pradesh, India.

Tel. No.:

91-1792-229739, 229779

Fax No.:

91-1792-229839

E-Mail :

vineet@meriodin.com 

info@meridian.com

Website :

www.meriodin.com

 

 

DIRECTORS

 

Name :

Mr. Vinod Gupta

Designation :

Managing Director

Address :

Surya Nagar, Chauhan Building, Rajgarh Road, Solan, 173212, Himachal Pradesh, , India.

Date of Birth/Age :

22/04/1943

Date of Appointment :

01.10.2007

 

 

Name :

Mrs. Madhu Gupta

Designation :

Whole-time Director

Address :

Surya Nagar, Chauhan Building, Rajgarh Road, Solan, 173212, Himachal Pradesh,  India.

Date of Birth/Age :

13/05/1947

Date of Appointment :

01.10.2007

 

 

Name :

Mr. Suresh Kumar Chaudhary

Designation :

Whole-time director

Address :

1082, DLF Colony, Ward-23, Rohtak, 124001, Haryana, India.

Date of Birth/Age :

02/06/1950

Date of Appointment :

01.10.2007

 

 

Name :

Mr. Satinder Singh

Designation :

Whole-time Director

Address :

6, Village Aanji, H.No. 622, Tehsil, Solan, 173212, Himachal Pradesh, India.

Date of Birth/Age :

20/12/1956

Date of Appointment :

01.10.2007

 

 

Name :

Mr. Vikas Agarwal

Designation :

Whole-time Director

 

 

 

 

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2006

 

Names of Shareholders

No. of Shares

Mr. Sumit Gupta

200

Mrs. Madhu Gupta

3500

Mr. Arun Trehan

400

Mrs. Sangeeta Trehan

100

Mr. Shiv Kumar Khosla

400

Mr. Jagmohan Malhotra

100

Mrs. Rashmi Khosla

100

Mr. Suresh Kumar Chaudhary

3100

Mr. Vinod Gupta

29100

Mrs. Shalika Agarwal

3000

Mr. Prem Vati

10000

Total

50000

 

 

Equity Share breakup (Percentage of Total Equity)

 

As on 31.03.2006

 

Sr. No.

Category

Percentage

1.

Directors or relatives of directors.

97.8

2.

Other top 5 Share Holders (Other than those listed above)

2.2

 

Total

100.00

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Marketing of Medicines.

 

 

Products :

Alimentry System

1.Antacid, Anti-ulcerantes

2. GIT regulators, Anti-flatulence

3. Antispasmodics

4. Laxatives and Purgatives

5. Anti-diarrhoea

6. Anti emetic

7. ORS Powder

 

Cardiovascular System:

1.Anti Anginal  drugs

2. Calcium channel  Blockers

3. Diuretics

 

Respiratory System:

1.Anti asthmatic Preparations

2. Cough and cold remedies

 

Neuro-Muscular System

1.Analgesic and Antipyretics

2. Anti inflammatory enzymes

3. Anti rheumatic, Anti-inflammatory, Analgesics

4. Minor Tranquilizers

5. Anti emetic drugs

6. Anti depressant

7. Muscle relaxants

 

 Antibiotics:

1. Tetracycline

2. Ciprofloxacin

3. Norfloxacin

4. Anti bacterial combinations

5. Anti fungal

6. Aminoglycosides

7. Quinolones

8. Other antibiotics

 

Other Chemo-therapeutics:

1. Anti amoebic

2. Anti helmintic

3. Anti viral

4. Anti septic

 

Genito Urinary Track system

1. Urinary Antiseptics

2. Urinary Infection antibiotics

3. Preparation for Vaginal Infection

4. For erectile dysfunction

 

Vitamins and minerals:

1 Vitamin B / with C

2. Vitamin C

3. Vitamin and Calcium

4. Multi Vitamins with Minerals

5. Pediatrics Dry Syp, Vitamins and Minerals

6. Anti anemic and Pre & Post natal vitamins

 

Allergy and Immune System:

1.  Anti histaminics

17. Anti allergics

 

 

PRODUCTION STATUS

 

Particulars

Actual Production

Tablet

144 million

Capsules

72 million ton

Liquids External Preparations

0.360 million Litre

Powder

6.25 million pouches

 

 

GENERAL INFORMATION

 

Bankers :

v      ABN AMRO Bank

v      Baghat Urban Co-op Bank Limited, Solan - 173212

v      HDFC Bank, Chandigarh

v      HDFC Bank, Solan

v      State Bank of India, Solan

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Jagmohan Chohda and Company, Chartered Accountant

Address :

Near LIC Building, The Mall, Solan, 172312, Himachal Pradesh, India.

 

 

CAPITAL STRUCTURE

 

 

Authorised Capital :

No. of Shares

Type

Value

Amount

250,000

Equity Shares

Rs. 10/- Each

Rs.  2.500 millions

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

50,000

Equity Shares

Rs. 10/- Each

Rs. 0.500 million

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2006

31.03.2005

31.03.2004

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.500

0.500

0.500

2] Share Application Money

0.000

1.070

0.000

3] Reserves & Surplus

15.280

3.884

0.569

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

15.780

5.454

1.069

LOAN FUNDS

 

 

 

1] Secured Loans

1.770

1.837

0.673

2] Unsecured Loans

0.350

0.535

0.586

TOTAL BORROWING

2.120

2.372

1.259

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

17.900

7.826

2.328

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

10.027

6.721

2.985

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

1.800

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

24.785

11.031

0.000

 

Sundry Debtors

11.045

4.682

0.000

 

Cash & Bank Balances

6.072

2.200

0.000

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

1.254

0.200

8.862

Total Current Assets

43.156

18.113

8.862

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

35.798

16.678

9.527

 

Provisions

1.291

0.337

0.000

Total Current Liabilities

37.089

17.015

9.527

Net Current Assets

6.067

1.098

(0.665)

 

 

 

 

MISCELLANEOUS EXPENSES

0.006

0.007

0.008

 

 

 

 

TOTAL

17.900

7.826

2.328

 

 

 

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2006

31.03.2005

31.03.2004

Sales Turnover

172.596

69.029

12.952

Other Income

0.110

0.455

1.058

Total Income

172.706

69.484

14.010

 

 

 

 

Profit/(Loss) Before Tax

12.736

3.667

0.586

Provision for Taxation

1.072

0.287

0.062

Profit/(Loss) After Tax

11.664

3.380

0.524

 

 

 

 

Expenditures :

 

 

 

 

Raw Material Consumed

136.736

52.085

0.000

 

Material and Factory Expenses

0.000

0.000

10.868

 

Consumption of stores and spares parts

5.178

2.017

0.000

 

Salaries, Wages, Bonus, etc.

7.734

3.956

0.000

 

Managerial Remuneration

0.240

0.240

0.000

 

Selling and Distribution Expenses

0.000

0.000

0.149

 

Payment to Auditors

0.005

0.005

0.000

 

Interest

0.238

0.203

0.000

 

Insurance Expenses

0.055

0.052

0.000

 

Personal Expenses

0.000

0.000

0.859

 

Financial Expenses

0.000

0.000

0.157

 

Power & Fuel

0.298

0.071

0.000

 

Depreciation & Amortization

1.499

1.594

0.623

 

Other Expenditure

7.987

5.594

0.766

Total Expenditure

159.970

65.817

13.423

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2006

31.03.2005

31.03.2004

PAT / Total Income

(%)

6.75

5.28

3.74

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

7.38

5.31

4.52

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.37

5.28

4.18

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.81

0.67

0.55

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.35

3.12

8.91

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.16

1.06

0.93

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

This form is for

Creation of Charge

Corporation identity number (CIN) or foreign company registrations number of the company 

U24231HP1997PLC020064

Name of the company

MERIDIAN MEDICARE LIMITED

Address

Village Shamti, Solan, 173212, Himachal Pradesh, India.

Type of Charges

Others

Whether consortium finance is involved

No

Whether joint charge involved

No

Number of charge holder(s)

1

Particular of the charge holder 

Name : Directors of Industries

City : Solan

State : Himachal Pradesh

ISO Country Code : IN

Pin Code : 173211

e-mail ID : info@merimed.com

Nature or description of the instrument creating or modifying the charge  

v      Agreement of Hypothecation for Central Investment Subsidy

v      Agreement for availing Central Investment Subsidy.

v      No objection letter from Bhagat Urban Co-operative Bank Limited, Solan for ceding first pari passu charge in favour of G.M. DIC, Solan

 

Date of the instrument creating charge

23.03.2007

Whether charge created or modified outside India

No

Amount Secure by the charge

Rs. 972.381 millions

Brief particulars of the principal terms and conditions and extent and operation of the charge

(d) Extent and operation of the charge

The charge shall rank pari passu with the charge of Bhagat Urban Co-operative Bank Limited, Solan

Short particulars of the Property charged  

Machinery and Equipment situated at the factory site of the company at Village Shamti, Solan, Himachal Pradesh.

Whether any of the property or interest therein under reference is not registered in the name of the company 

No

 

Form 8

 

Name of the company

M/s MERIDIAN MEDICARE LIMITED

Presented By

Mr. Vinod Gupta, Director

1) Date and description of instrument creating the 

    change

17.04.2003 :

Agreement for Cash Credit / Overdraft

2) Amount secured by the charge/amount owing on 

    the securities of charge

Rs. 0.600 millions

3) Short particular of the property charged. If the

    property acquired is subject to charge, date of   

    the acquired of the property should be given

General lien and right of set of and combine account without notice and charge on all movable property of every description coming into the possession and control of the said bank on account of the borrowers or any one of them or for the time being held by the said bank on behalf , of the borrowers or any one of them whether alone or jointly with others in India or elsewhere including without prejudice to this generality, any moneys, bank drafts, deposits, deposit receipts for moneys, promissory notes, bills of exchange, cheques, hundies, stocks and shares, goods and merchandise, bills of lading, railway receipts, lorry receipts, government bills with inspection notes and other bills in course of collection and other documents of title of immovable property and mercantiles documents of every description including hire-purchase agreement  or contracts, (other than those affecting immovable property and requiring registration under law relating to registration) and other documents evidencing the title of the borrowers as creditors or members of any corportation association, registered society, company or syndicate in India or elsewhere.

4) Gist of the terms and conditions and extent and

    operation of the charge.

Rate of Interest: Interest shall be charged at 15 percent per annum subject to the change in interest rates made by the Reserve Bank of India from time to time.

Repayable on demand.

 Extent and operation of charge: 100%.

5) Name and Address and description of the

    person entitled to the charge.

The Baghat Urban Co-operative Bank Limited Solan – 173212, (H.P.)

 

 

Form 8 Particular for creation or modification of charges 

 

Name of the company

M/s MERIDIAN MEDICARE LIMITED

Presented By

Mr. Vinod Gupta, Director

1) Date and description of instrument creating the 

    change

08.11.2004

v      Term Loan Agreement dated 08.11.2004

v      Deed of Hypothecation dated 08.11.2004

 

2) Amount secured by the charge/amount owing on 

    the securities of charge

Rs. 1.000 millions

3) Short particular of the property charged. If the

    property acquired is subject to charge, date of   

    the acquired of the property should be given

Land and Machinery Purchased from/out of the advance made by the Bank.

4) Gist of the terms and conditions and extent and

    operation of the charge.

Rate of Interest: Interest shall be charged at 12.50 % per annum or as per RBI Directors / Bank rules.

Repayment : Repayable in 120 monthly Instalments of Rs. 14000/- starting from 08.12.2004

Extent and operation of charge : 100%

5) Name and Address and description of the

    person entitled to the charge.

The Baghat Urban Co-operative Bank Limited, Solan – 173212, (H.P.)

 

Fixed Assets:

 

v      Land and Building

v      Vehicles

v      Furniture and Fixtures

v      Car

v      Water Tank

v      Plant and Machinery

v      EPABX

v      Computers

v      Laboratory Equipments

 

COMPANY PROFILE:


Subject is in the service of society by manufacturing and marketing quality medicines since 1988. Shri Vinod Gupta who has 25 years experience of marketing pharmaceutical products and 18 years experience in manufacturing quality medicines promoted the Company.


Initially the products were manufactured and marketed by the name of Meridian Laboratories Pvt. Ltd established at Saproon (Solan) in the year 1987. The new unit has been established at Shamti, 5 Km. from Solan, on Rajgarh Road by the name of Meridian Medicare Ltd in the year 2002.


The unit has three sections and manufactures products in the forms of Tablets, Capsules and Syrups. The unit is set up in pristine surroundings of the Shivalik foothills in Himachal Pradesh and has been built and equipped keeping in view the requirements laid down by GMP and Schedule M (revised) of the Drugs & Cosmetics Act, 1940. They hold GMP certification as well as ISO 9001:2000 certificate.


The packing and designs of products are very sophisticated and of highest standards. The products are well accepted by Medical fraternity, sold all over India, and supplied to various Government Institutions, health clinics and hospitals.

 

PRODUCTION LINES AND SECTIONS:

 

The factory has three production lines in three sections:.

 

. Tablet – Two Sections (Betalactum and Non Betalactum)


.  Capsule – Two Sections (Betalactum and Non Betalactum)


.  Syrup – Two Sections (Oral and External Applications)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

The market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

 

 

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

The Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 40.02

UK Pound

1

Rs. 78.77

Euro

1

Rs. 62.97

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, they have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions